Spinal Muscular Atrophy Treatment News and Information

What is Spinal Muscular Atrophy? (Definition)

Spinal muscular atrophy is a disorder of genetic origins which affects the ability to control muscle movement. The condition is caused by a loss of motor neurons in the spinal cord and the brainstem (part of the brain that is connected to the spinal cord). The loss of motor neurons leads to weakness and wasting (atrophy) of muscles used for various normal activities such as crawling, walking, sitting up, and controlling head movement. In severe cases of spinal muscular atrophy, the muscles used for breathing and swallowing are affected. There are many types of spinal muscular atrophy distinguished by the pattern of features, severity of muscle weakness, and age when the muscle problems begin.

See below for updated news and information regarding Spinal Muscular Atrophy including new medical research, treatment options and advancements. 

Latest Spinal Muscular Atrophy Treatment News and Research

Spinal Muscular Atrophy Treatment Research: Experiments in Mice May Help Boost Newly FDA-Approved Therapy for Spinal Muscular Atrophy

(SOURCE: JOHNS HOPKINS MEDICINE) - Johns Hopkins researchers along with academic and drug industry investigators say they have identified a new biological target for treating spinal muscular atrophy. They report they have evidence that an experimental medicine aimed at this target works as a “booster” in conjunction with a drug called nusinersen that was recently FDA-approved to improve symptoms of the disorder ...
Read More

Spinal Muscular Atrophy Research News: Stanford patient is first infant to receive lifesaving drug for neurodegenerative disease

(SOURCE: STANFORD UNIVERSITY MEDICAL CENTER) - Zoe Harting became the first baby in the world to receive an experimental drug that her doctors hoped would save the lives of thousands of infants like her. Zoe has spinal muscular atrophy type 1, a degenerative neuromuscular disease that kills most patients by their second birthday. Before she began receiving the drug, 7-month-old Zoe was ...
Read More